EUVIMED · CrossrefZeitschrift
Nuclear Medicine and Biology
ISSN 0969-8051 · Elsevier BV
Neueste Artikel
Preclinical evaluation of a CD137-targeted PET tracer for detection of inflammatory arthritis
Spatial resolution and image quality of radionuclides for PET imaging
GMP production of [68Ga]Ga-ATH001, a tracer targeting the platelet-derived growth factor receptor beta (PDGFRβ) for a microdose trial in humans
PSMA and SSTR2 Dual-Targeting Theranostic Agents for Neuroendocrine-differentiated Prostate Cancer (NEPC)
Recent advances in understanding and improving the stability of 211At-radiopharmaceuticals
Myocardial kinetics of [11C]β-hydroxybutyrate in healthy pigs: Comparison of positron emission tomography imaging vs. arteriovenous balance methods
Novel dibutyl ether resin for the purification of the Auger emitter antimony-119 from tin targets
Preclinical evaluation of [225Ac]Ac-PSMA-617 and in vivo effect comparison in combination with [177Lu]Lu-PSMA-617 for prostate cancer
Production and purification of radiolabeling-ready 132/135La from the irradiation of metallic natBa targets with low energy protons
Terbium-161 in nuclear medicine: Preclinical and clinical progress in comparison with lutetium-177
Radiolabeling yield dependency of post-dry distillation decay of astatine-211
Solid phase extraction chromatography-based radiochemical isolation of cyclotron-produced 51Mn from enriched 54Fe targets
Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy
Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci
First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparaginate, [18F]RP-115
Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer
Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders
Production, purification and formulation of nanoradiopharmaceutical with 211At: An emerging candidate for targeted alpha therapy
A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation
Improved purification of cyclotron [68Ga]GaCl3 for the production of 68Ga radiopharmaceuticals
64Cu production via the 68Zn(p,nα)64Cu nuclear reaction: An untapped, cost-effective and high energy production route
Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[18F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine
Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply
Co-production of 155Tb and 152Tb irradiating 155Gd / 151Eu tandem target with a medium energy α-particle beam
Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Radioligand Therapy Applications
[99mTc]Tc-PSMA-T4 a potential radiofarmaceutical for SPECT/CT imaging of metastatic prostate cancer
Direct clinical comparison of scaffold proteins [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 for imaging of HER2-positive breast cancer
The emerging role of artificial intelligence and digital twins in pre-clinical molecular imaging
Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo
Cyclotron production of 103Pd using a liquid target
Jahrgänge
2026 · 482025 · 5752024 · 692023 · 4742022 · 6192021 · 2762020 · 772019 · 2382018 · 972017 · 1252016 · 1282015 · 1612014 · 2852013 · 1632012 · 1772011 · 1522010 · 3132009 · 1282008 · 1202007 · 1242006 · 1402005 · 1112004 · 1392003 · 1142002 · 1132001 · 1232000 · 1211999 · 1341998 · 1171997 · 1371996 · 1461995 · 1491994 · 1441993 · 148
EUVIMED